Engineers Gate Manager LP

SEC CIK: 0001620220
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overview All 13F holders of ADAPY Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of ADAPY by Engineers Gate Manager LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−14,294−100.0%	Sold out	Holders
Q2 2022	14,294	$24.0K	<0.1%	+14,294	New	Holders
Q2 2021	0	$0	0.0%	−39,100−100.0%	Sold out	Holders
Q1 2021	39,100	$208.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.